{
  "report_rows": [
    {
      "kpi": "Q2 2026 revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.145B vs. cons $2.135B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.04 vs. cons $2.01",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~25.9% vs. cons 25.8%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$8.53 midpoint vs. cons $8.49 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Reported revenue growth guidance",
      "prediction": "LOWER",
      "answer": "guide ~3.5% midpoint vs. cons 3.9% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic constant-currency revenue growth guidance",
      "prediction": "LOWER",
      "answer": "guide ~2.0% midpoint vs. cons 2.4% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted operating margin guidance",
      "prediction": "LOWER",
      "answer": "guide ~25.3% vs. cons 25.4% (Q3 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.7,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Despite Q2 adjusted EPS of ~$2.04 vs. $2.01 consensus, an FY2026 guide of ~$8.53 vs. $8.49 consensus implies limited underlying upside after buybacks and leaves second-half organic growth and margin estimates vulnerable to downward revisions.",
  "day5_confidence": "MEDIUM"
}